Associate Director, Global Insights & Analytics – Pipeline & Portfolio

For Current Kite Pharma Employees and Contractors: Please log onto your Internal Career Site to apply for this job. At Kite we believe every employee deserves a great leader. As a people leader now or in the future, we expect that you will model and create an environment of inclusion, be intentionally focused on the hiring, development, growth and retention of talent, and empower teams to align and achieve goals. Job Description We have an exciting opportunity at Kite for an Associate Director, Global Insights Analytics. This position will be on the Pipeline Portfolio team and will support Kite’s commercialization efforts for pipeline assets in Cell Therapy, inform the lifecycle management process, and collaborate with key stakeholders to guide product and disease area strategy. This opportunity is based at Kite’s HQ in Santa Monica, CA but a remote arrangement may be considered for the right candidate and include travel to HQ (~3x per quarter depending on business needs). In this role, you will participate actively in commercial efforts by providing an objective and detailed understanding of current and future markets, product performance, customers, and competitors. You will also be responsible for generating foundational market understanding within the Cell Therapy area through the implementation of market research and forecasting activities. Key Responsibilities Forecasting Leverage primary and secondary research insights and cross-functional partners’ inputs to design and develop, and maintain patient-based (epi) forecasting models Produce analogues, formulate assumptions, and define opportunities and risks associated with the forecast Conduct forecast scenario analysis to inform and support decisions by cross-functional partners (e.g., BD, Commercial, Marketing, R D, Finance) Provide guidance and input for short-term demand planning Synthesize market dynamics to identify potential drivers impacting performance and Assumes full responsibility for accuracy and reliability of analyses Market Research Independently lead projects, coordinating input from the cross-functional team to scope, design and manage the execution of qualitative and quantitative market research studies with physicians, patients, and payers Integrate results of market research, latest competitive intelligence, as well as secondary metrics into actionable insights Oversee vendors to determine appropriate research methodology, ensure project alignment to business goals and guide execution and reporting General Effectively collaborate with and communicate to key stakeholder groups to support strategic and tactical decision making (e.g., opportunity assessments, brand planning) with insightful analysis that accurately and objectively reflect the current market dynamics, product performance, customers, and competitors to augment the potential of cell therapy Basic Qualifications Doctorate and 2 years of experience OR Master’s Degree and 8 years of experience OR Bachelor’s Degree and 10 years of experience OR Associate and 12 years of experience OR High School Degree and 14 years of experience Preferred Qualifications Experience in forecasting and market research within the biotech / pharmaceutical industry Understanding of the hematology / oncology clinical landscape and the business of cell therapy Prior experience in Lymphoma or Myeloma Demonstrated ability to work in frequent collaboration with others and work cross-functionally Experience in managing and supporting multiple projects in a fast-moving entrepreneurial environment, with changing priorities and significant time pressures Strategic agility to adapt expertise in forecasting and primary market research to a biopharmaceutical field where standard frameworks do not exist Demonstrated ability to extract business insights and provide strategic recommendations based on analysis findings Excellent communicator who is comfortable presenting to senior key team members and defending forecast assumptions Experience working on a co-commercialized asset The salary range for this position is: $168,980.00 - $218,680.00. Kite considers a variety of factors when determining base compensation, including experience, qualifications, and geographic location. These considerations mean actual compensation will vary. This position may also be eligible for a discretionary annual bonus, discretionary stock-based long-term incentives (eligibility may vary based on role), paid time off, and a benefits package. Benefits include company-sponsored medical, dental, vision, and life insurance plans*. For additional benefits information, visit: https://www.gilead.com/careers/compensation-benefits-and-wellbeing * Eligible employees may participate in benefit plans, subject to the terms and conditions of the applicable plans. Kite is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies with a goal of providing rapid, long-term durable response and eliminating the burden of chronic care. The company is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system's ability to recognize and kill tumors. Kite is based in Santa Monica, CA. For more information on Kite, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma. For jobs in the United States: As an equal opportunity employer, Gilead Sciences Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, gender, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status, or other non-job related characteristics or other prohibited grounds specified in applicable federal, state and local laws. In order to ensure reasonable accommodation for individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans' Readjustment Act of 1974, and Title I of the Americans with Disabilities Act of 1990, applicants who require accommodation in the job application process may contact careers@gilead.com for assistance. Following extensive monitoring, research, consideration of business implications and advice from internal and external experts, Kite has made the decision to require all U.S., Canada, Australia, Singapore, and Hong Kong employees and contractors to receive the COVID-19 vaccines as a condition of employment. “Full vaccination” is defined as two weeks after both doses of a two-dose vaccine or two weeks since a single-dose vaccine has been administered. Anyone unable to be vaccinated, either because of a sincerely held religious belief or a medical condition or disability that prevents them from being vaccinated, can request a reasonable accommodation. For more information about equal employment opportunity protections, please view the 'Know Your Rights' poster. NOTICE: EMPLOYEE POLYGRAPH PROTECTION ACT YOUR RIGHTS UNDER THE FAMILY AND MEDICAL LEAVE ACT PAY TRANSPARENCY NONDISCRIMINATION PROVISION Our environment respects individual differences and recognizes each employee as an integral member of our company. Our workforce reflects these values and celebrates the individuals who make up our growing team. Gilead provides a work environment free of harassment and prohibited conduct. We promote and support individual differences and diversity of thoughts and opinion. For Current Kite Pharma Employees and Contractors: Please log onto your Internal Career Site to apply for this job. Change The World With Us Everyone at Kite is grounded by one common goal – curing cancer. Every day, we aim to establish a direct line between that purpose and our day-to-day work. We are creating Kite together, with the recognition that the best teams are built by the best people. We maintain an attitude of curiosity, and creativity with each challenge as we develop a new market for cancer therapies. We appreciate and respect one another, and most importantly, we don’t take success for granted. While we’ve come a long way to make what others viewed as impossible, possible, we know one thing is certain. Today is just the beginning. Following extensive monitoring, research, consideration of business implications and advice from internal and external experts, Kite has made the decision to require all U.S., Canada, Australia, Singapore, and Hong Kong employees and contractors to be fully vaccinated against COVID-19 as a condition of employment. The health of our employees, contractors, their loved ones, our partners and the communities and people we serve is a top priority. Vaccination is the most effective way currently available to deliver on that priority. The purpose of the vaccination requirement is to minimize the spread of COVID-19 in the workplace and support the health and safety of our communities. A person is considered fully vaccinated two weeks after the second dose of a two-dose vaccine or two weeks after a single-dose vaccine has been administered. Anyone unable to be vaccinated, either because of a sincerely held religious belief or a medical condition or disability that prevents them from being vaccinated, can request an accommodation.